Type-1 Cannabinoid Receptor Signaling in Neuronal Development

Publisher： Karger

E-ISSN： 1423-0313|90|1-2|19-39

ISSN： 0031-7012

Source： Pharmacology, Vol.90, Iss.1-2, 2012-07, pp. : 19-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2

By Yang Longhe   Li Yanting   Ren Jie   Zhu Chenggang   Fu Jin   Lin Donghai   Qiu Yan  

International Journal of Molecular Sciences, Vol. 15, Iss. 8, 2014-08 ,pp. : 13637-13648

MDPI

Access to resources Recommend Favorite

Synthesis and Preliminary Biological Evaluation of Indol-3-yl-oxoacetamides as Potent Cannabinoid Receptor Type 2 Ligands

By Moldovan Rareş-Petru   Deuther-Conrad Winnie   Horti Andrew G.   Brust Peter  

Molecules, Vol. 22, Iss. 1, 2017-01 ,pp. : 77-77

MDPI

Access to resources Recommend Favorite

Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor

By Mu Linjing   Slavik Roger   Müller Adrienne   Popaj Kasim   Čermak Stjepko   Weber Markus   Schibli Roger   Krämer Stefanie D.   Ametamey Simon M.  

Pharmaceuticals, Vol. 7, Iss. 3, 2014-03 ,pp. : 339-352

MDPI

Access to resources Recommend Favorite

The Inhibitory Effect of S-777469, a Cannabinoid Type 2 Receptor Agonist, on Skin Inflammation in Mice

By  

Pharmacology, Vol. 99, Iss. 5-6, 2017-02 ,pp. : 259-267

Karger

Access to resources Recommend Favorite

The Nonpsychotropic Cannabinoid Cannabidiol Modulates and Directly Activates Alpha-1 and Alpha-1-Beta Glycine Receptor Function

By  

Pharmacology, Vol. 83, Iss. 4, 2009-02 ,pp. : 217-222

Karger

Access to resources Recommend Favorite